Default: Hematology

ISSN: 1024-5332

Journal Home

Journal Guideline

Hematology Q3 Unclaimed

Taylor and Francis Ltd. United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Hematology is a journal indexed in SJR in Hematology with an H index of 50. It has a price of 2840 €. It has an SJR impact factor of 0,543 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,543.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Scopus WOS
Categories: Hematology (Q3)
Price

2840 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Hematology

0,543

SJR Impact factor

50

H Index

189

Total Docs (Last Year)

373

Total Docs (3 years)

6531

Total Refs

758

Total Cites (3 years)

360

Citable Docs (3 years)

2.01

Cites/Doc (2 years)

34.56

Ref/Doc

Comments

No comments ... Be the first to comment!



Best articles by citations

Soluble VEGF/sFLt1 ratio is an independent predictor of AML patient out come

View more

Multiple littoral cell angioma of the spleen in a case of myelodysplastic syndrome

View more

Mixed-type autoimmune haemolytic anaemia: Unusual cases and a case associated with splenic T cell angioimmunoblastic non-Hodgkins lymphoma

View more

Clinical and Laboratory Study of an Episode of Cefotetan-Induced Severe Hemolytic Anemia

View more

Evaluation of growth parameters in patients with thalassemia major

View more

Targeted somatic mutation of the BCL6 proto-oncogene and its impact on lymphomagenesis

View more

Hereditary hemochromatosis

View more

Iron deficiency anaemia and evaluation of the utility of iron deficiency indicators among healthy Nigerian children

View more

Molecular analysis of patients with severe congenital factor X deficiency: First report from north and northwest of Iran

View more

GATA2 null mutation associated with incomplete penetrance in a family with Emberger syndrome

View more

Characteristics and management of primary and other immune thrombocytopenias: Spanish registry study

View more

Combined chemotherapy for acute promyelocytic leukemia: a meta-analysis

View more
SHOW MORE ARTICLES

Evaluation of cardiac and hepatic iron overload in thalassemia major patients with T2* magnetic resonance imaging

View more

Hemochromatosis gene mutations may affect the survival of patients with myelodysplastic syndrome

View more

Recombinant Factor VIIa used to Control Massive Haemorrhage During Renal Transplantation Surgery; Vascular Graft Remained Patent

View more

Analysis of clinical characteristics and prognostic factors of multiple myeloma: a retrospective single-center study of 787 cases

View more

Haemoglobin F, A2, and S levels in subjects with or without sickle cell trait in south-eastern Gabon

View more

Lymphoproliferative Disease

View more

Elevation of CD16+CD56+ NK-cells and down-regulation of serum interleukin-21 (IL-21) and IL-1a after splenectomy in relapsed hemophagocytic lymphohistiocytosis of unknown cause

View more

Predictive parameters for imatinib failure in patients with chronic myeloid leukemia

View more

The role of long noncoding RNA HOTAIR in the acquired multidrug resistance to imatinib in chronic myeloid leukemia cells

View more

Modeling for tertiary structure of globin chain in Hemoglobin Suan-Dok disorder

View more

Clonal expanded TCR Vbeta T cells in patients with APL

View more

Fish consumption and risk of non-Hodgkin lymphoma: A meta-analysis of observational studies

View more

FAQS